ストックスクリーナーアプリを入手
0.4313
1.13%
0.0048
前日終値:
$0.4265
開ける：
$0.4137
24時間の取引高:
112.62K
Relative Volume:
0.84
時価総額：
$22.35M
収益：
$30.31M
当期純損益:
$-22.84M
株価収益率:
-0.9584
EPS:
-0.45
ネットキャッシュフロー:
$-22.61M
1週間 パフォーマンス:
-11.27%
1か月 パフォーマンス:
-12.36%
6か月 パフォーマンス:
-61.83%
1年 パフォーマンス:
-66.04%
1日の値動き範囲:
$0.4137
$0.451
1週間の範囲:
$0.4137
$0.52
52週間の値動き範囲:
$0.4122
$1.30
Enzo Biochem Inc Stock (ENZ) Company Profile
ENZ を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENZ
Enzo Biochem Inc
|
0.4313 | 22.35M | 30.31M | -22.84M | -22.61M | -0.45 |
|
TMO
Thermo Fisher Scientific Inc
|
500.16 | 196.14B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.85 | 150.17B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
415.87 | 34.36B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
116.69 | 33.28B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
177.39 | 31.62B | 15.41B | 1.37B | 2.11B | 7.50 |
Enzo Biochem Inc Stock (ENZ) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2011-10-18 | 繰り返されました | Rodman & Renshaw | Mkt Outperform |
| 2009-09-23 | 開始されました | Rodman & Renshaw | Mkt Outperform |
| 2007-09-13 | 開始されました | Lazard Capital | Buy |
Enzo Biochem Inc (ENZ) 最新ニュース
Enzo Biochem to delist from NYSE, move to OTCQX market By Investing.com - Investing.com South Africa
Enzo Biochem to delist from NYSE, move to OTCQX market - Investing.com India
Enzo Biochem (ENZ) to Voluntarily Delist from NYSE, Move to OTCQ - GuruFocus.com
Enzo Biochem to voluntarily delist from NYSE and transfer trading of shares to OTCQX; shares fall - MSN
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX - The Manila Times
Enzo Biochem Announces Notification to New York Stock - GlobeNewswire
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily - Bluefield Daily Telegraph
NYSE Delisting Alert: Enzo Biochem Moving to OTCQXWhat Shareholders Must Know - StockTitan
Here’s Why Enzo Biochem (ENZ) Declined in Q4 - Yahoo Finance
StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
ENZ Stock Down Following Q2 Earnings, Revenues Decline Y/Y - Nasdaq
Enzo Biochem Inc (ENZ) Reports Q2 Fiscal 2025 Revenue of $7.3 Mi - GuruFocus.com
Enzo Biochem: Fiscal Q2 Earnings Snapshot - The Pioneer
Enzo Biochem Reports Decline in Quarterly Revenues - TipRanks
Enzo Biochem Inc. ($0.01 Par Value) (ENZ) reports earnings - Quartz
Enzo Biochem Stages Comeback: Q2 Shows 18% Growth, Key Segment Returns to Profit - StockTitan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Enzo Biochem: Fiscal Q2 Earnings Snapshot -March 17, 2025 at 04:30 pm EDT - Marketscreener.com
ENZO BIOCHEM INC SEC 10-Q Report - TradingView
Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results - GlobeNewswire
Protein Stability Analysis Market Future Business - openPR
Enzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.com - Defense World
Enzo Biochem, Inc. to Host Earnings Call - ACCESS Newswire
Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com - Defense World
Protein Stability Analysis Market Generated Opportunities, - openPR
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - Defense World
Enzo Biochem, Inc.'s (NYSE:ENZ) 28% Share Price Plunge Could Signal Some Risk - Simply Wall St
Enzo Biochem stock hits 52-week low at $0.51 amid challenges - MSN
ENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024 - MSN
Neuroscience Antibodies and Assays Market to Grow by USD 2.20 Billion from 2024-2028, Rising Neurological Disorders Boost Growth, Report on How AI is Redefining Market LandscapeTechnavio - The Malaysian Reserve
NYAG’s Enforcement of Mandated Cybersecurity Safeguards Sends Expensive Shock Waves through Varying Industries - Law.com
StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Enzo Biochem stock hits 52-week low at $0.63 amid market challenges - Investing.com Canada
Enzo Biochem stock hits 52-week low at $0.63 amid market challenges By Investing.com - Investing.com South Africa
Kingdom Capital Advisors Q4 2024 Investor Letter - Seeking Alpha
Enzo Biochem settles class action for $7.5 million - MSN
Enzo Biochem Inc (ENZ) 財務データ
収益
当期純利益
現金流量
EPS
0.80%
0.71%
大文字化:
|
ボリューム (24 時間):